Kewaunee Scientific (NASDAQ:KEQU) & Profusa (NASDAQ:PFSA) Head to Head Contrast

Profusa (NASDAQ:PFSA) and Kewaunee Scientific (NASDAQ:KEQU) are both small-cap healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their analyst recommendations, valuation, profitability, dividends, earnings, institutional ownership and risk.

Institutional and Insider Ownership

9.8% of Profusa shares are owned by institutional investors. Comparatively, 32.7% of Kewaunee Scientific shares are owned by institutional investors. 15.0% of Profusa shares are owned by company insiders. Comparatively, 14.1% of Kewaunee Scientific shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Profitability

This table compares Profusa and Kewaunee Scientific’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Profusa	N/A	N/A	-1,731.09%
Kewaunee Scientific	3.41%	14.10%	5.55%

Analyst Recommendations

This is a breakdown of current ratings for Profusa and Kewaunee Scientific, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Profusa	1	0	0	0	1.00
Kewaunee Scientific	0	1	0	0	2.00

Volatility & Risk

Profusa has a beta of 0.49, suggesting that its stock price is 51% less volatile than the S&P 500. Comparatively, Kewaunee Scientific has a beta of 0.73, suggesting that its stock price is 27% less volatile than the S&P 500.

Valuation and Earnings

This table compares Profusa and Kewaunee Scientific”s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Profusa	$100,000.00	15.07	-$35.82 million	($5,619.96)	-0.00
Kewaunee Scientific	$282.00 million	0.36	$9.62 million	$3.22	10.88

Kewaunee Scientific has higher revenue and earnings than Profusa. Profusa is trading at a lower price-to-earnings ratio than Kewaunee Scientific, indicating that it is currently the more affordable of the two stocks.

Summary

Kewaunee Scientific beats Profusa on 10 of the 12 factors compared between the two stocks.

About Profusa

NorthView Acquisition Corporation does not have significant operations. The company intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It also intends to focus its search on businesses that are focused on healthcare sector. The company was incorporated in 2021 and is based in New York, New York. NorthView Acquisition Corporation is a subsidiary of NorthView Sponsor I, LLC.

About Kewaunee Scientific

Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks. The company's laboratory products are used in chemistry, physics, biology, and other general science laboratories in the pharmaceutical, biotechnology, industrial, chemical, commercial, educational, government, and health care markets; and technical products are used in facilities manufacturing computers and light electronics and by users of computer and networking furniture. It sells its products primarily through dealers, its subidiaries, and a national distributor. The company was founded in 1906 and is headquartered in Statesville, North Carolina.